According to the new market research report Debrillators Market is projected to reach USD 10.88 Billion by 2022 Billion in 2017, growing at a CAGR of 3.1%. providing public access defibrillation, and rising numbers of training & awareness programs across the globe are driving the growth of this market.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=549
By product, the implantable cardioverter defibrillators segment is expected to hold the largest share of the market in 2017
The ICDs are implantable defibrillators (ICDs) and external defibrillators (ICDs) and external defibrillators. The ICDs are segmented into implantable defibrillators. T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy (CRT-Ds). The external classifieds segment is further classified into a manual classified as an external defibrillator. Cardioverter defibrillators (WCDs). The ICDs segment is expected to account for the largest share of the global defibrillators market in 2017.Factors such as development of technologically advanced devices with extended longevity, rapid growth in the number of implant procedures, and increasing adoption of cardiac therapy therapies (CRT-Ds) and S-ICD systems this segment.
By end user, the public access markets segment is expected to be the fastest growing segment in the forecast period
Pre-hospital care settings; home care settings; and alternate care facilities. The public access markets segment is is expected to grow at the end user, the defibrillators market is segmented into hospitals, clinics, and cardiac centers; Growth in this segment is attributed to the development of advanced AEDs, rising cases of sudden cardiac arrest, and out-of-hospital settings, and increasing numbers of public access delibriation programs across the globe.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=549
North America is expected to dominate the market in 2017
Geographically, the defibrillators market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the market in 2017, followed by Europe. The largest share of North America can primacy be attributed to the rising population population, increasing incidence of cardiovascular disease, and continuous technological advancements & product innovations in the region.
The key players in the defibrillators market include Medtronic (Ireland), St. Jude Medical (US), Boston Scientific (US), Koninklijke Philips NV (Netherlands), ZOLL Medical (US), BIOTRONIK (Germany), Physio-Control (US) ), Cardiac Science (US), LivaNova (UK), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey).
